Sanofi India, a Rs. 1,225 crore plus MNC, has posted lower profit during the third quarter ended September 2012 to Rs. 51.3 crore from Rs. 54.8 crore in the corresponding period of last year, a de-growth of 6.4 per cent. Its net sales increased sharply by 26.8 per cent to Rs. 396.6 crore from Rs. 312.7 crore. Its EBDITA moved up by 31.1 per cent to Rs. 107.10 crore from Rs. 81.71 crore. The board of directors has recommended interim dividend of Rs. 4 per share of Rs. 10 each for the year ending December 2012.

The company's net sales for nine months period increased by 22.6 per cent to Rs. 1093 crore from Rs. 892 crore in the similar period of last year. Its net profit, however, declined by 15 per cent to Rs. 131.9 crore from Rs. 155.1 crore in the last period. EBDITA worked out to Rs. 264.1 crore as compared to Rs. 247.3 crore, a growth of 6.8 per cent.

During the quarter ended September 2012, Sanofi has changed its accounting policy with respect of amortisation of Goodwill. It has been decided to amortise Goodwill on acquisition of business over a period of 10 years starting from the date of acquisition. In the past, Goodwill was not amortised but tested for impairment. As a result of this change, profit after tax for the quarter and nine months ended September 30, 2012 is lower by Rs. 7.8 crore, which includes Rs. 5.7 crore from the period upto June 2012.